Target intelligence / Profile preview

Immunoglobulin kappa variable 2D-28 (IGKV2D-28)

Target
IGKV2D-28
Molecular classification
Other (Immunoglobulin variable region), Immunoglobulin superfamily
01

Overview

Immunoglobulin kappa variable 2D-28 (IGKV2D-28) is a protein encoded by the IGKV2D-28 gene located on chromosome 2 within the immunoglobulin kappa locus (2p11.2). It encodes the variable region of the kappa (κ) light chain in immunoglobulins, crucial for the formation of the antigen recognition domain of antibodies. Immunoglobulins, also known as antibodies, are composed of two identical heavy chains and two identical light chains that participate in recognizing and neutralizing antigens as part of the humoral immune response. The variable domains of immunoglobulin heavy and light chains are generated by somatic recombination and are responsible for the diversity and specificity of antibody-antigen interactions. Expression levels of IGKV2D-28 have been explored as a candidate biomarker in disorders such as gestational diabetes mellitus, highlighting its potential utility in research and clinical diagnostics, although not as a direct therapeutic target.

Other names
IGKV2D-28Ig kappa chain V-II region FRIg kappa chain V-II region GM607Ig kappa chain V-II region MILIg kappa chain V-II region TEWA3IGKV2D28
02

Biological functions

Antigen recognitionAdaptive immune responseFormation of antigen-binding domain of immunoglobulins (antibodies)
03

Disease associations

Other (Potential biomarker or indicator, not a direct disease mediator)Possible association as an inflammatory biomarker in conditions such as gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) due to immune system involvement
04

Biomarkers

Expression of IGKV2D-28 has been investigated as a candidate RNA biomarker for gestational diabetes mellitus and may have a biomarker role in inflammatory states, but not as a protein biomarker for targeted therapy

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2D-28 (IGKV2D-28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2D-28 (IGKV2D-28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call